S32.0 S22.0 C79.5 M46.2
Conditions
Interventions
Group 1: Patients treated with a POSEIDON ST vertebral body replacement implant
Sponsors
SIGNUS Medizintechnik GmbH
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Inclusion criteria are the indication for surgical treatment with POSEIDON ST and the availability of a consent form. Only patients who have given their written consent to participate in accordance with data protection regulations will be included in the study.
Exclusion criteria
Exclusion criteria: - Age <18 years - Participants unable to give consent, e.g. due to cognitive impairments - Pregnant women who are breastfeeding - Patients for whom consent is not available
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Follow-up times: 3 months, 1 year, 2 years Fusion rate (radiological, functional images) Migration and sintering (radiological) Corrective gain loss (radiological) Safety and implant associated complications (general and surgical complications) | — |
Secondary
| Measure | Time frame |
|---|---|
| Follow-up times: 3 months, 1 year, 2 years Functional outcome (ODI, EQ-5D) Postoperative pain relief (VAS, analgesic consumption) Neurological status (Frankel scale) Patient satisfaction (scale) Quality of life (ODI, EQ-5D) | — |
Countries
Germany
Contacts
Public ContactChristoph – E. Heyde
Universitätsklinikum Leipzig AöR
Outcome results
None listed